LifeStance Health LFST 深 沪
等待开盘 09-01 09:30:00 美东时间
12.27
-0.040
-0.32%
华盛通- 最 高12.32
- 今 开12.23
- 成交量 60.85万股
- 最 低 12.0419
- 昨 收 12.31
- 总市值 46.88亿
- 52周最高 12.965
- 市盈率 静 496.76
- 换手率 0.16%
- 52周最低 4.77
- 委 比 8.56%
- 总股本 3.82亿
- 历史最高 29.811
- 量 比 0.32
- 振 幅 2.26%
- 历史最低 3.74
- 每 手 1
- 风险率 2.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅1610.53%！Ascendiant Capital上调Alzamend Neuro目标价至26美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Alzamend Neuro"买入"评级，目标价从25美元升至26美元；Tigress Financial：维持Legence"买入"评级，目标价从125美元升至130美元
08-20 08:39
JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $13
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $9 to $13.
08-15 00:04
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
LifeStance Health Group shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, the company issued Q3 sales guidance above estimates.
LifeStance Health Group shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance above estimates. Also, the company issued Q3 sales guidance above estimates.
08-06 19:49
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est
LifeStance Health Gr (NASDAQ:LFST) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.
08-06 18:15
LifeStance Health Gr Q2 EPS $0.06 Beats $0.04 Estimate, Sales $435.354M Beat $414.577M Estimate
LifeStance Health Gr (NASDAQ:LFST) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.04 by 50 percent. This is a 700 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $435.354 million...
08-06 18:14
美股大行评级 | 最高120美元！大小摩等7家大行集体上调英特尔目标价；汇丰首予SpaceX"持有"评级，目标价115美元
今日重点评级关注：HC Wainwright & Co.：维持居里"买入"评级，目标价从17美元升至43美元；花旗：维持Klaviyo"买入"评级，目标价从31美元升至34美元
07-27 14:02
美股大行评级 | 富国银行上调亚马逊目标价从313美元升至322美元；潜在涨幅370.99%！HC Wainwright上调Greenwich LifeSciences目标价至69美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从50美元升至69美元；高盛：维持Taysha Gene Therapies"买入"评级，目标价从11美元升至13美元
07-22 11:35
Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Canaccord Genuity raised the price target for Lifestance Health Group Inc (NASDAQ:LFST) from $11 to $13. Canac...
07-21 19:51
Canaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $13
Canaccord Genuity analyst Richard Close maintains LifeStance Health Gr (NASDAQ:LFST) with a Buy and raises the price target from $11 to $13.
07-21 19:36
